Real-time
Euronext Paris
11:10:57 2024-04-29 EDT
|
5-day change
|
1st Jan Change
|
34.2
EUR
|
+1.33%
|
|
+1.03%
|
-14.97%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
859.8
|
637.4
|
724
|
626.3
|
880.6
|
586
|
586
|
-
|
Enterprise Value (EV)
1 |
643
|
435
|
501.7
|
404.4
|
651.8
|
698.3
|
465
|
315.1
|
P/E ratio
|
15.2
x
|
15.7
x
|
27.6
x
|
21.9
x
|
19.7
x
|
14.2
x
|
15.6
x
|
12.7
x
|
Yield
|
2.96%
|
2.88%
|
2.3%
|
2.66%
|
2.17%
|
3.01%
|
2.9%
|
3.33%
|
Capitalization / Revenue
|
1.42
x
|
1.14
x
|
1.41
x
|
1.38
x
|
1.65
x
|
1.42
x
|
1.15
x
|
1.09
x
|
EV / Revenue
|
1.06
x
|
0.78
x
|
0.98
x
|
0.89
x
|
1.22
x
|
1.42
x
|
0.92
x
|
0.59
x
|
EV / EBITDA
|
4.58
x
|
4.22
x
|
4.76
x
|
6.67
x
|
8.58
x
|
3.82
x
|
5.81
x
|
3.5
x
|
EV / FCF
|
17.6
x
|
32.6
x
|
10.5
x
|
18.1
x
|
13.5
x
|
4.68
x
|
9.45
x
|
5.7
x
|
FCF Yield
|
5.69%
|
3.06%
|
9.48%
|
5.52%
|
7.43%
|
21.4%
|
10.6%
|
17.5%
|
Price to Book
|
1.76
x
|
1.26
x
|
1.42
x
|
1.18
x
|
1.58
x
|
1.02
x
|
1.35
x
|
1.07
x
|
Nbr of stocks (in thousands)
|
17,566
|
17,511
|
17,508
|
17,519
|
17,368
|
17,362
|
17,362
|
-
|
Reference price
2 |
48.95
|
36.40
|
41.35
|
35.75
|
50.70
|
33.75
|
33.75
|
33.75
|
Announcement Date
|
19-03-13
|
20-03-11
|
21-03-10
|
22-03-10
|
23-03-21
|
24-04-02
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
604.2
|
557.1
|
513.6
|
455.2
|
534.2
|
493.2
|
508
|
537
|
EBITDA
1 |
140.4
|
103
|
105.5
|
60.61
|
75.97
|
79.95
|
80
|
90.05
|
EBIT
1 |
106
|
66.92
|
38.18
|
46.84
|
63.45
|
42.29
|
46.6
|
61.55
|
Operating Margin
|
17.55%
|
12.01%
|
7.44%
|
10.29%
|
11.88%
|
8.57%
|
9.17%
|
11.46%
|
Earnings before Tax (EBT)
|
104
|
64.38
|
37.22
|
46.11
|
59.2
|
-
|
-
|
-
|
Net income
1 |
57.46
|
40.63
|
26.21
|
28.56
|
44.67
|
35.83
|
37.7
|
46.3
|
Net margin
|
9.51%
|
7.29%
|
5.1%
|
6.27%
|
8.36%
|
7.26%
|
7.42%
|
8.62%
|
EPS
2 |
3.230
|
2.320
|
1.500
|
1.630
|
2.570
|
2.375
|
2.170
|
2.655
|
Free Cash Flow
1 |
36.57
|
13.33
|
47.57
|
22.33
|
48.45
|
65.3
|
49.2
|
55.25
|
FCF margin
|
6.05%
|
2.39%
|
9.26%
|
4.91%
|
9.07%
|
12.61%
|
9.69%
|
10.29%
|
FCF Conversion (EBITDA)
|
26.05%
|
12.94%
|
45.09%
|
36.84%
|
63.78%
|
81.68%
|
61.5%
|
61.35%
|
FCF Conversion (Net income)
|
63.64%
|
32.81%
|
181.49%
|
78.18%
|
108.46%
|
157.54%
|
130.5%
|
119.33%
|
Dividend per Share
2 |
1.450
|
1.050
|
0.9500
|
0.9500
|
1.100
|
1.015
|
0.9800
|
1.125
|
Announcement Date
|
19-03-13
|
20-03-11
|
21-03-10
|
22-03-10
|
23-03-21
|
24-04-02
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2020 S1
|
2021 Q2
|
2021 S1
|
2021 Q3
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
---|
Net sales
1 |
256.7
|
253.6
|
98.76
|
189.9
|
117.8
|
145.8
|
111
|
256.8
|
128.4
|
149.1
|
132.3
|
107.6
|
239.9
|
121.1
|
160
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
16.03
|
1.496
|
-
|
-11.04
|
-
|
-
|
-
|
19.99
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
38.9
|
Operating Margin
|
6.24%
|
0.59%
|
-
|
-5.81%
|
-
|
-
|
-
|
7.79%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
1.448
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-0.975
|
-
|
-9.514
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-0.38%
|
-
|
-5.01%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-07-18
|
20-09-09
|
21-09-09
|
21-09-09
|
21-12-10
|
22-06-21
|
22-09-21
|
-
|
22-10-21
|
23-03-21
|
23-04-28
|
23-10-02
|
-
|
23-10-20
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
217
|
202
|
222
|
222
|
229
|
280
|
121
|
271
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
36.6
|
13.3
|
47.6
|
22.3
|
48.5
|
65.3
|
49.2
|
55.3
|
ROE (net income / shareholders' equity)
|
11.5%
|
8.2%
|
5.17%
|
5.49%
|
8.2%
|
7.25%
|
8.9%
|
8.55%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
27.70
|
28.90
|
29.10
|
30.40
|
32.10
|
33.20
|
24.90
|
31.40
|
Cash Flow per Share
2 |
4.740
|
2.900
|
3.900
|
1.900
|
3.380
|
3.960
|
4.480
|
4.860
|
Capex
1 |
39.4
|
37.5
|
20.7
|
11
|
10.2
|
21.7
|
20.2
|
22.5
|
Capex / Sales
|
6.52%
|
6.74%
|
4.03%
|
2.41%
|
1.92%
|
4.19%
|
3.98%
|
4.19%
|
Announcement Date
|
19-03-13
|
20-03-11
|
21-03-10
|
22-03-10
|
23-03-21
|
24-04-02
|
-
|
-
|
Last Close Price
33.75
EUR Average target price
39.6
EUR Spread / Average Target +17.33% Consensus |
1st Jan change
|
Capi.
|
---|
| -14.97% | 626M | | +35.04% | 5.92B | | -15.13% | 4.51B | | -9.75% | 3.15B | | +2.14% | 3.1B | | -6.82% | 2.42B | | +47.87% | 1.97B | | -7.89% | 1.68B | | +0.09% | 1.65B | | -12.97% | 1.53B |
Alternative Medicine
|